Clinical Trial Update: PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial PRONTO studies prophylactic versus on-demand use of tocilizumab, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Myeloma, Lymphoma | Phase 2 | Status: RECRUITING